US2006172955A1PendingUtilityA1
Antibiotic/benzoyl peroxide dispenser
Est. expiryDec 12, 2020(expired)· nominal 20-yr term from priority
A61P 43/00A61P 31/04A61P 17/10A61K 8/02A61K 8/38A61K 8/671A61K 2800/88A61K 8/60A61M 35/003A61K 8/8158A61Q 19/00A61K 33/40A61K 8/35A61K 8/34A61Q 19/04A61K 8/44A61K 8/86A61K 8/347A61Q 19/02A61K 8/8147A61K 2800/52A61K 8/676A61K 31/74A61K 8/39A61K 8/8152A61K 45/06A61K 9/06A61K 31/70A61K 8/31
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Two separate compositions, one containing an effective anti-acne treating amount of a first active ingredient and one containing a second active ingredient that is incompatible with the first active ingredient are packaged within and dispensed from a common dispenser. By packaging these two active ingredients in this manner, long shelflife and convenient dispensing and application are provided.
Claims
exact text as granted — not AI-modified1 . An apparatus comprising:
a first chamber containing a first composition, the first composition comprising an effective acne-treating amount of an antibiotic; a second chamber containing a second composition comprising a retinoid; pump means for moving the first and second compositions out of the first and second chambers; and one or more outlets for dispensing the first and second compositions.
2 . An apparatus as in claim 1 wherein the retinoid is selected from the group consisting of retinol, retinoic acid, retinyl palmitate, retinyl propionate, retinyl acetate and synthetic retinoid mimetics.
3 . An apparatus as in claim 2 wherein the antibiotic is selected from the group consisting of erythromycin, clindamycin, tetracycline, derivatives of erythromycin, clindamycin or tetracycline and pharmaceutically acceptable salts of erythromycin, clindamycin or tetracycline.
4 . An apparatus comprising:
a first chamber containing a first composition, the first composition comprising an effective acne-treating amount of benzoyl peroxide; a second chamber containing a second composition comprising a retinoid; pump means for moving the first and second compositions out of the first and second chambers; and one or more outlets for dispensing the first and second compositions.
5 . An apparatus as in claim 4 wherein the retinoid is selected from the group consisting of retinol, retinoic acid, retinyl palmitate, retinyl propionate, retinyl acetate and synthetic retinoid mimetics.
6 . A method of treating acne comprising
simultaneously pumping a first composition and a second composition from first and second chambers, respectively, the first composition comprising an effective acne-treating amount of a first active ingredient selected from the group consisting of antibiotics and benzoyl peroxide, the second composition comprising a retinoid; and contacting the first composition and second composition with the skin of a person afflicted with acne.
7 . A method as in claim 6 wherein the first active ingredient is an antibiotic.
8 . A method as in claim 7 wherein the antibiotic is selected from the group consisting of erythromycin, clindamycin, tetracycline, derivatives of erythromycin, clindamycin or tetracycline and pharmaceutically acceptable salts of erythromycin, clindamycin or tetracycline.
9 . A method as in claim 6 wherein the retinoid is selected from the group consisting of retinol, retinoic acid, retinyl palmitate, retinyl propionate, retinyl acetate and synthetic retinoid mimetics.
10 . A method as in claim 6 wherein the first active ingredient is benzoyl peroxide.
11 . A method as in claim 10 wherein benzoyl peroxide comprises from about 0.1 to about 25 weight percent of the second composition.
12 . A method as in claim 6 wherein the first composition is substantially anhydrous.
13 . A method as in claim 6 wherein the second composition is substantially anhydrous.Join the waitlist — get patent alerts
Track US2006172955A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.